IL-6R inhibition with tocilizumab (TCZ) improves quality of life measures in patients with active rheumatoid arthritis despite mtx therapy: The option study
- Resource Type
- Journal
- Source
RHEUMATOLOGY ; APR 2008, 47 pII43-pII43, 1p. Supplement: 2- Subject
- Language
- English
- ISSN
- 14620324